Based on the previous studies of prognostic biomarkers in NSCLC patients [27], [28] and the involvement of nucleolin in tumor angiogenesis, we hypothesized that nucleolin may serve as an important marker for tumor neoangiogenesis and is associated with a poor prognosis in early NSCLC after radical surgery. This evidence concerns the gene NUCLEOLIN and non-small cell lung carcinoma.